Y. Wang et al.
2-[3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]-5-
[(2,3-difluorophenoxy)methyl]-1,3,4-oxadiazole
2-[3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]-5-
[(5-fluoro-2-methylphenoxy)methyl]-1,3,4-oxadiazole
(16h, C18H12BrClFN5O2)
(16e, C17H9BrClF2N5O2)
Yield 78.2%; white solid; m.p.: 103–104 °C; 1H NMR
(500 MHz, DMSO-d6): d = 8.54 (dd, 3J = 4.6 Hz,
4J = 1.4 Hz, 1H, pyridine-H), 8.26 (dd, 3J = 8.1 Hz,
4J = 1.4 Hz, 1H, pyridine-H), 7.69 (dd, 3J = 8.1 Hz,
4J = 4.6 Hz, 1H, pyridine-H), 7.58–7.51 (m, 1H, ben-
zene-H, pyridine-H), 7.17–6.98 (m, 3H, benzene-H), 5.53
(s, 2H, –CH2–) ppm; 19F NMR (471 MHz, DMSO-d6):
d = -137.60, -159.54 ppm; 13C NMR (126 MHz,
DMSO-d6): d = 162.99, 156.24, 150.97 (dd, J = 245.1,
10.1 Hz), 148.28, 147.47, 140.83 (dd, J = 246.3, 14.6 Hz),
140.71, 130.21, 128.92, 128.70, 124.82 (d, J = 8.8 Hz),
124.78, 112.99, 111.77, 111.74, 111.07 (d, J = 17.2 Hz),
61.20 ppm; HR-MS (ESI?): m/z calcd for C17H9BrClF2-
N5O2 ([M?H]?) 467.96690, found 467.96698.
Yield 78.2%; white solid; m.p.: 95–97 °C; 1H NMR
(500 MHz, DMSO-d6): d = 8.49 (dd, 3J = 4.7 Hz,
4J = 1.5 Hz, 1H, pyridine-H), 8.24 (dd, 3J = 8.1 Hz,
4J = 1.5 Hz, 1H, pyridine-H), 7.68 (dd, 3J = 8.1 Hz,
4J = 4.7 Hz, 1H, pyridine-H), 7.56 (s, 1H, pyrazole-H),
3
4
7.16 (dd, JF–H = 11.3 Hz, JH–H = 4.0 Hz, 1H, benzene-
3
4
H), 6.95 (dd, JF–H = 11.1 Hz, JH–H = 2.5 Hz, 1H,
3
4
benzene-H), 6.72 (td, JH–H = 8.4 Hz, JH–H = 2.5 Hz,
1H, benzene-H), 5.43 (s, 2H, –CH2–), 2.04 (s, 3H, –CH3)
ppm; 19F NMR (471 MHz, DMSO-d6): d = -114.33 ppm;
13C NMR (126 MHz, DMSO-d6): d = 161.70 (d,
J = 244.2 Hz), 162.22, 156.59, 156.12, 156.04, 147.86,
147.30, 139.71, 131.58, 131.50, 129.98, 129.41, 128.98,
126.66, 122.74, 122.71, 112.57, 108.44 (d, J = 20.7 Hz),
100.08 (d, J = 25.9 Hz), 59.95, 15.64 ppm; HR-MS
(ESI?): m/z calcd for C18H12BrClFN5O2 ([M?H]?)
463.99197, found 463.99213.
4-[[5-[3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-
yl]-1,3,4-oxadiazol-2-yl]methoxy]-2,6-difluorobenzonitrile
(16f, C18H8BrClF2N6O2)
Yield 78.2%; white solid; m.p.: 76–77 °C; 1H NMR
(500 MHz, CDCl3): d = 8.48 (dd, 3J = 4.5 Hz,
4J = 1.5 Hz, 1H, pyridine-H), 7.87 (d, 3J = 8.0 Hz,
4J = 1.5 Hz, 1H, pyridine-H), 7.40 (dd, 3J = 8.0 Hz,
4J = 4.6 Hz, 1H, pyridine-H), 7.07 (s, 1H, pyrazole-H),
6.64 (s, 1H, benzene-H), 6.62 (s, 1H, benzene-H), 4.87 (s,
2H, –CH2–) ppm; 19F NMR (471 MHz, CDCl3):
d = -101.86 ppm; 13C NMR (126 MHz, CDCl3):
d = 163.74 (d, J = 247.9 Hz), 163.62 (d, J = 247.9 Hz),
159.04 (t, J = 13.5 Hz), 156.66, 147.84, 147.32, 139.72,
129.84, 129.41, 128.96, 126.70, 115.17, 112.62, 98.98 (d,
J = 7.2 Hz), 98.81 (d, J = 7.2 Hz), 98.37, 98.16, 97.96,
59.92 ppm; HR-MS (ESI?): m/z calcd for C18H8BrClF2-
N6O2 ([M?H]?) 492.96215, found 492.96211.
2-[3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]-5-
[(4-(trifluoromethyl)phenoxy]methyl)-1,3,4-oxadiazole
(16i, C18H10BrClF3N5O2)
Yield 78.2%; white solid; m.p.: 97–98 °C; 1H NMR
(500 MHz, CDCl3): d = 8.44 (dd, 3J = 4.6 Hz,
4J = 1.3 Hz, 1H, pyridine-H), 7.89 (dd, 3J = 8.0 Hz,
3
4J = 1.3 Hz, 1H, pyridine-H), 7.56 (d, J = 8.6 Hz, 2H,
benzene-H), 7.42 (dd, 3J = 8.0 Hz, 4J = 4.6 Hz, 1H,
pyridine-H), 7.11 (s, 1H, pyrazole-H), 7.02 (d,
3J = 8.6 Hz, 2H, benzene-H), 5.27 (s, 2H, –CH2–) ppm;
19F NMR (471 MHz, CDCl3): d = -61.60 ppm; 13C NMR
(126 MHz, CDCl3): d = 161.84, 159.67, 156.66, 147.86,
147.29, 139.69, 129.86, 129.42, 128.97, 127.34, 127.31,
126.65,
124.68
(q,
J = 32.8 Hz),
124.17 (d,
J = 271.2 Hz), 114.85, 112.61, 59.59 ppm; HR-MS
(ESI?): m/z calcd for C18H10BrClF3N5O2 ([M?H]?)
499.97313, found 499.97339.
2-[3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]-5-
[(3,5-difluorophenoxy)methyl]-1,3,4-oxadiazole
(16g, C17H9BrClF2N5O2)
Yield 78.2%; white solid; m.p.: 91–92 °C; 1H NMR
(500 MHz, CDCl3): d = 8.43 (dd, 3J = 4.6 Hz,
4J = 1.4 Hz, 1H, pyridine-H), 7.90 (d, 3J = 8.1 Hz,
4J = 1.4 Hz, 1H, pyridine-H), 7.44 (dd, 3J = 8.1 Hz,
4J = 4.6 Hz, 1H, pyridine-H), 7.10 (s, 1H, pyrazole-H),
6.51–6.39 (m, 3H, benzene-H), 5.18 (s, 2H, –CH2–) ppm;
19F NMR (471 MHz, CDCl3): d = -107.64 ppm; 13C
NMR (126 MHz, CDCl3): d = 163.74 (d, J = 247.9 Hz),
163.62 (d, J = 247.9 Hz), 159.04 (t, J = 13.5 Hz), 156.66,
147.84, 147.32, 139.72, 129.84, 129.41, 128.96, 126.70,
112.62, 98.97 (d, J = 7.2 Hz), 98.80 (d, J = 7.2 Hz),
98.37, 98.16, 97.96, 59.92 ppm; HR-MS (ESI?): m/z calcd
for C17H9BrClF2N5O2 ([M?H]?) 467.96690, found
467.96698.
2-[3-Bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]-5-
[(3-bromo-4-fluorophenoxy)methyl]-1,3,4-oxadiazole
(16j, C17H9Br2ClFN5O2)
Yield 78.2%; white solid; m.p.: 117–118 °C; 1H NMR
(500 MHz, CDCl3): d = 8.44 (dd, 3J = 4.6 Hz,
4J = 1.5 Hz, 1H), 7.90 (dd, 3J = 8.1 Hz, 4J = 1.5 Hz,
3
4
1H), 7.44 (dd, J = 8.1 Hz, J = 4.6 Hz, 1H), 7.12 (dd,
4
3J = 5.4 Hz, J = 3.1 Hz, 1H), 7.11 (s, 1H, pyrazole-H),
7.03 (t, J = 8.5 Hz, 1H, benzene-H), 6.85 (dt, J = 9.0,
3.4 Hz, 1H, benzene-H), 5.18 (s, 2H, –CH2–) ppm; 13C
NMR (126 MHz, CDCl3): d = 161.87, 156.61, 154.82 (d,
J = 242.2 Hz), 153.68, 147.85, 147.32, 139.71, 129.88,
129.42, 128.97, 126.67, 119.99, 116.98 (d, J = 24.3 Hz),
115.26, 112.60, 109.51 (d, J = 22.9 Hz), 60.42 ppm; HR-
123